Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus

Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus

US Patent 8022175 · Granted Sep 20, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HA-specific influenza virus attenuated vaccine comprising mutations in segment 72022
Newcastle disease virus monoclonal antibodies2010